Francisco M. Marty
Brigham & Women's Hospital and Dana-Farber Cancer Institute
Boston
MA 02115
USA
Name/email consistency: high
- Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial. Marty, F.M., Ljungman, P., Papanicolaou, G.A., Winston, D.J., Chemaly, R.F., Strasfeld, L., Young, J.A., Rodriguez, T., Maertens, J., Schmitt, M., Einsele, H., Ferrant, A., Lipton, J.H., Villano, S.A., Chen, H., Boeckh, M. Lancet. Infect. Dis (2011)
- Role of (1-->3)-beta-D-glucan in the diagnosis of invasive aspergillosis. Marty, F.M., Koo, S. Med. Mycol. (2009)
- Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis. Marty, F.M., Bryar, J., Browne, S.K., Schwarzberg, T., Ho, V.T., Bassett, I.V., Koreth, J., Alyea, E.P., Soiffer, R.J., Cutler, C.S., Antin, J.H., Baden, L.R. Blood (2007)
- Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation. Marty, F.M., Lowry, C.M., Cutler, C.S., Campbell, B.J., Fiumara, K., Baden, L.R., Antin, J.H. Biol. Blood Marrow Transplant. (2006)
- Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis. Marty, F.M., Yeh, W.W., Wennersten, C.B., Venkataraman, L., Albano, E., Alyea, E.P., Gold, H.S., Baden, L.R., Pillai, S.K. J. Clin. Microbiol. (2006)
- Reactivity of (1-->3)-beta-d-glucan assay with commonly used intravenous antimicrobials. Marty, F.M., Lowry, C.M., Lempitski, S.J., Kubiak, D.W., Finkelman, M.A., Baden, L.R. Antimicrob. Agents Chemother. (2006)
- Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin. Marty, F.M., Lowry, C.M., Rodriguez, M., Milner, D.A., Pieciak, W.S., Sinha, A., Fleckenstein, L., Baden, L.R. Clin. Infect. Dis. (2005)
- Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study. Marty, F.M., Lee, S.J., Fahey, M.M., Alyea, E.P., Soiffer, R.J., Antin, J.H., Baden, L.R. Blood (2003)
- Disseminated trichosporonosis caused by Trichosporon loubieri. Marty, F.M., Barouch, D.H., Coakley, E.P., Baden, L.R. J. Clin. Microbiol. (2003)









